Range
1.31 - 1.42
Vol / Avg.
16.8M/15.3M
Div / Yield
-
52 Wk
0.76 - 3.46
Mkt Cap
133M
Payout Ratio
-
Open
1.36
P/E
-
EPS
-0.04
Shares
97.5M
Outstanding
97.5M
Total Float
-
load more
Sector: Health Care.Industry: Pharmaceuticals
Cocrystal Pharma Inc is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). CC-31244 is currently being evaluated in a Phase 2a study for the treatment of hepatitis C as part of a cocktail for ultra-short therapy of 4 to 6 weeks.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.040
REV0
Q4 2020Est.ActualSurprise
EPS-0.010
REV510.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
COCPCocrystal Pharma9.2%133M

Cocrystal Pharma Frequently Asked Questions

Q

How do I buy Cocrystal Pharma (COCP) stock?

A

You can purchase shares of Cocrystal Pharma (NASDAQ: COCP) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cocrystal Pharma's (COCP) competitors?

Q

What is the target price for Cocrystal Pharma (COCP) stock?

A

The latest price target for Cocrystal Pharma (NASDAQ: COCP) was reported by HC Wainwright & Co. on November 12, 2020. The analyst firm set a price target for 4.50 expecting COCP to rise to within 12 months (a possible 229.67% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cocrystal Pharma (COCP)?

A

The stock price for Cocrystal Pharma (NASDAQ: COCP) is $1.365 last updated Today at 7:26:00 PM.

Q

Does Cocrystal Pharma (COCP) pay a dividend?

A

There are no upcoming dividends for Cocrystal Pharma.

Q

When is Cocrystal Pharma (NASDAQ:COCP) reporting earnings?

A
Cocrystal Pharma’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is Cocrystal Pharma (COCP) going to split?

A

There is no upcoming split for Cocrystal Pharma.

Q

What sector and industry does Cocrystal Pharma (COCP) operate in?

A

Cocrystal Pharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.